Key Insights

Highlights

Treatment Research

4 treatments under study, led by Standard Open Surgery

Research Leaders

8 sponsors active, led by Royal Surrey County Hospital NHS Foundation Trust

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Recruiting3

Clinical Trials (3)

Showing 3 of 3 trials
NCT05859074Phase 1Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NCT06638593Not ApplicableRecruiting

MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.

NCT05842629Recruiting

Improved Diagnosis of Ovarian Cancer

Showing all 3 trials

Research Network

Common Treatments

  • Standard Open Surgery1
  • Mq7191
  • Mirrorsfrozen Protocol1
  • Pembrolizumab1

Active Sponsors

  • Royal Surrey County Hospital NHS Foundation Trust1
  • Aarhus University Hospital1
  • Regionshospitalet Horsens1
  • University of Aarhus1
  • Randers Regional Hospital1

Top Investigators

Related Conditions

  • Ovarian Cancer2
  • Ovarian Cysts2
  • Merkel Cell Carcinoma1
  • Hnscc1
  • Angiosarcoma1

Activity Timeline